Shattuck Labs Inc (STTK NASDAQ) stock market data APIs
$4.8228
0.17(3.5%)
as of November 12, 2026
Try our APIs with
free plan!
Shattuck Labs Inc Financial Data Overview
Price chart is built with
Anychart
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Prev. Close
4.8228
Open
4.9948
High
5.0545
Low
4.7105
52 wk Range
1.855-8.33
Market Cap
514 M
Shares Outstanding
102 M
EPS
-0.14
Beta
1.126
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Shattuck Labs Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shattuck Labs Inc data using free add-ons & libraries
Get Shattuck Labs Inc Fundamental Data
Shattuck Labs Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -68 575 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-11-05
- EPS/Forecast: -0.1
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shattuck Labs Inc News
New
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Beats Revenue Estimates
Denali Therapeutics Inc. (DNLI) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to a loss of $0.74 per share a year ago. These f...
What Shattuck Labs Stock Topped the Market on Monday
Not one, but two, analysts published new takes on Shattuck Labs (NASDAQ: STTK) in the past few days. Since both prognosticators were optimistic about the clinical-stage biotech's future, investors wer...
Shattuck Labs GAAP EPS of -$0.12 in-line
* Shattuck Labs press release [https://seekingalpha.com/pr/20614116-shattuck-labs-reports-second-quarter-2026-financial-results-and-recent-business-highlights] (STTK [https://seekingalpha.com/symbol...
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
A new analyst note was the key factor behind the mini-rally in Shattuck Labs (NASDAQ: STTK) stock on the last trading day of the week. The clinical-stage biotech's shares closed the day almost 5% high...
Get Shattuck Labs Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.